Sir Andrew J MCMICHAEL is a Professor of Molecular Medicine at the Nuffield Department of Medicine at the University of Oxford, UK. For more than 50 years he has worked on cytotoxic T-lymphocytes (CTL) responses against viruses, especially influenza. • He first showed that human cytotoxic T lymphocyte (CTL) responses to influenza virus were HLA …
Team Group archives :
Dr. Tim Mosmann
Dr. Tim Mosmann is Director of the human immunology center at the University of Rochester, with more than 40 years of experience and major contributions in T cell mediated immunity Expertise • Established a high-throughput proliferation and cytotoxicity assay for cytokines • Used this assay to show that there were discrete patterns of cytokines produced …
Dr Fergal Hill, MD
Dr. Fergal HILL is co-inventor of the pro-immunogenic tags oligoDOM® (OVX313) in its first and second generation. He has published in prominent international journals and is the coauthor of more than 15 patents or patent applications. Prior experience: • CSO, IMAXIO (2000-2017) • Researcher, European Molecular Biology Laboratory, Heidelberg, Germany (1999-2000) • Researcher, Laboratory of …
Dr Nathalie Garcon, Pharm D, PhD
Dr. Nathalie Garçon has more than 30 years of expertise in vaccinology, from research to manufacturing, in particular immunology, adjuvant and formulation technologies Expertise: • 5 new innovation projects selected, with implementation path defined and milestone established for go/no go decision • Restructuration of North America RD, with downsizing from 4 to 2 sites, and …
Prof. Jeffrey Almond, PhD
Prof. Jeffrey Almond is a pre-eminent vaccinologist. He has more than 40 years of expertise in the field of vaccines and Influenza Expertise: • His scientific contributions include the first demonstration that a single gene can determine host range – a finding highly relevant to understanding evolution of new Influenza pandemic strains • Completion of …